chronic kidney disease - Articles and news items

1000 patient Phase III study required for Armetheon before FDA approval

Industry news / 10 February 2017 / Niamh Marriott, Digital Editor

Armetheon has reached agreement with the FDA for a single 1000 patient final pivotal trial for its drug candidate, tecarfarin, prior to filing an NDA…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+